NRX Pharmaceuticals Q4 EPS $0.20 Up From $(0.77) YoY, Sales $983.000K
NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc. NRXP | 0.00 |
NRX Pharmaceuticals (NASDAQ:
NRXP) reported quarterly earnings of $0.20 per share. This is a 125.97 percent increase over losses of $(0.77) per share from the same period last year. The company reported $983.000 thousand in sales this quarter.
